T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions - Wikidata - wikimedia - TriplyDB

T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions

T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions

http://www.wikidata.org/entity/Q35143874

about

The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans Innate immunity and inflammation in ageing: a key for understanding age-related diseases Alterations in reversible protein histidine phosphorylation as intracellular signals in cardiovascular disease Role of Helicobacter pylori infection in pathogenesis of atherosclerosis Batf3-dependent CD8α+ Dendritic Cells Aggravates Atherosclerosis via Th1 Cell Induction and Enhanced CCL5 Expression in Plaque Macrophages.Immunomodulation of vascular diseases: atherosclerosis and autoimmunity Chlamydia pneumoniae-induced memory CD4+ T-cell activation in human peripheral blood correlates with distinct antibody response patterns Chlamydia pneumoniae infection promotes a proliferative phenotype in the vasculature through Egr-1 activation in vitro and in vivo.Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective.Association between leukocyte and metabolic syndrome in urban Han Chinese: a longitudinal cohort study.The cytokines within the carotid plaque in symptomatic patients with internal carotid artery stenosis.Programmed cell death-1 deficiency exacerbates T cell activation and atherogenesis despite expansion of regulatory T cells in atherosclerosis-prone mice.Lack of association between JAK3 gene polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis.Genetical genomics of Th1 and Th2 immune response in a baboon model of atherosclerosis risk factors Interleukin-1 associations in inflammatory bowel disease and the enteropathic seronegative spondylarthritis.Persistent Chlamydia pneumoniae infection of cardiomyocytes is correlated with fatal myocardial infarction Valsartan Attenuates Atherosclerosis via Upregulating the Th2 Immune Response in Prolonged Angiotensin II-Treated ApoE(-/-) Mice Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis Helicobacter pylori and extragastric diseases--other Helicobacters.TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque.T cells and cytokines in atherogenesis.Molecular mimicry between Helicobacter pylori antigens and H+, K+ --adenosine triphosphatase in human gastric autoimmunity.Relation between objective measures of atopy and myocardial infarction in the United States.Disruption of TGF-beta signaling in T cells accelerates atherosclerosis.Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease T-helper type 1 bias in healthy people is associated with cytomegalovirus serology and atherosclerosis: the Multi-Ethnic Study of Atherosclerosis Core2 1-6-N-glucosaminyltransferase-I is crucial for the formation of atherosclerotic lesions in apolipoprotein E-deficient mice In vivo imaging of the effect of LPS on arterial endothelial cells: molecular imaging of heat shock protein 60 expression.Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling.Influence of CD4+/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease.T helper cell polarization in healthy people: implications for cardiovascular disease Association of single-nucleotide polymorphisms in JAK3, STAT4, and STAT6 with new cardiovascular events in incident dialysis patients Actin is a target of T-cell reactivity in patients with advanced carotid atherosclerotic plaques.Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease.Functional and homeostatic defects of regulatory T cells in patients with coronary artery disease.Chlamydophila pneumoniae infection in patients undergoing carotid artery stent.Chronic Chlamydia pneumoniae infection may promote coronary artery disease in humans through enhancing secretion of interleukin-4.Cannabinoids and atherosclerotic coronary heart disease.HIV-specific immune dysregulation and atherosclerosis.Readapting the adaptive immune response - therapeutic strategies for atherosclerosis.

P2860

Q24648765-BCDF9866-6AB7-48C6-ACE7-92D30646219C Q24814846-926F2583-1104-4450-BD0F-0E2CFE14E175 Q26782883-9B57D5C6-BA32-4FDA-AB5D-8FA32CEE1626 Q27002402-FF2AB0EC-6BDD-4E73-A013-B6C605FAE7B4 Q30847000-C2196A66-FD12-4AC3-A70A-B89110657A94 Q33770999-80076354-1A67-4225-AA87-618ED27295AE Q33825748-1BA52A21-4BFD-4018-8EA9-8B909B8538C1 Q33927267-98CCEF1A-B15C-44C3-8816-5DFAE2908AFB Q34357562-AC408DD5-5E1F-4E90-BE59-149F357ACD09 Q34499775-38B49073-9F7D-43D7-A49F-2CB8BBF4C484 Q34812110-B88AE5C1-6C4B-41C6-A44A-23FB5DD8C6F7 Q35137584-F9E89315-7B52-4745-BE83-6668654D415B Q35178124-9E1ED86A-DEBC-4935-AEBB-31E2AEB7C911 Q35223445-BFBD693A-203D-40B3-AE5F-CE08658841B9 Q35309145-33338A55-7AF2-4805-8085-7A13A6A0C8B4 Q35570353-1A2A7061-C33D-46E9-8FC7-42AFAC4626B0 Q35707073-541A2A61-24A8-4D34-9518-28E782258754 Q35709096-7FB1EF8D-F36D-46A7-9707-067024B8FE0F Q35878346-6270BFDD-B4B7-430B-AA1E-8F7B7A9913E9 Q36227892-8C880657-0CCA-4C4B-AB58-B22120E84F07 Q36283482-80BD35A3-BA49-479D-9DA0-6D2E542D8C24 Q36371806-024A6056-D28E-4765-B4CA-D1C209018194 Q36431457-15C67141-095F-4787-8DE2-D008AEA21C22 Q36524547-7479EC64-1EFF-4DB0-B03C-2FB3263819C1 Q36563015-057D4BD4-CEC0-4288-97B0-346B7DC55541 Q36974273-2ACA5E1E-AFB3-453F-9BD1-3958AD840E19 Q37153149-8CB89AE3-5E80-41BB-9469-D071215396F1 Q37171018-ADE9C59C-20F9-4706-AEAE-E752314CE227 Q37200836-DF88388F-86A7-4133-A852-5F9C023ABE22 Q37230396-20DA8E4F-A443-4887-813C-AA3B3B4D15B6 Q37250335-89A1B9B6-9750-491F-BAD8-E102B5F19C59 Q37347718-E09E6D20-FB9A-48B0-B8A8-C2F39FC92244 Q37351550-BC39DD81-388C-4D09-BE93-23CC1ECB0898 Q37606079-D7FAE0F3-B233-423A-93BC-41BD82A97A67 Q37664079-1C6E9948-29AE-4A5F-873A-5A66B45A3761 Q37851529-19EC25AD-5246-404A-AA14-B7FA61A249A4 Q37861245-D042D96A-E9E0-48BF-8540-94A2C53C52E2 Q37978806-2D808B07-27FA-45CF-AAC9-F318E1AD9F01 Q38013681-E14A1B4B-1F26-40B8-BCE9-7A69EEF48D3E Q38774904-99D11129-24C7-41EA-B3CA-09580B714097

P2860

T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions

http://www.wikidata.org/entity/Q35143874

description

2003 nî lūn-bûn

@nan

2003 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions

@ast

T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions

@en

type

label

T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions

@ast

T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions

@en

prefLabel

T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions

@ast

T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions

@en

P1433

Q35143874-3A5C3368-109A-437E-9A48-F3BC4B459990

P1476

Q35143874-6F39E473-3C68-425E-A694-4C6089737669

P2093

Q35143874-221C7334-C602-42B5-B887-38F7386DEA2B

Q35143874-47ABF339-A1FB-4D38-86B4-F38B9C749BD3

Q35143874-5F4AA881-FEBB-4669-8F4D-3739DD7F2B5D

Q35143874-8D8ED5D5-9B1B-4676-A7C1-7F42547D07BA

Q35143874-93C3D2AE-C9E5-4CD3-AEFF-FFA048034EEB

Q35143874-A23F1218-4111-41FC-9FB2-D4980AEDDD50

Q35143874-A50922C4-49AD-4709-8014-D13DA7881205

Q35143874-DEADB4EA-CC03-4857-A04A-0BBAB2203B90

Q35143874-E0BBE875-D5D0-4FDE-97EC-5FD12AF6299A

P2860

Q35143874-0739784B-2972-45E9-AB01-8901480F20CD

Q35143874-0F654E87-9C9B-4B44-BA51-922160130A1D

Q35143874-16FD1B8B-2B00-4B35-8A67-3ACE059EB899

Q35143874-1DD5B38E-648E-4722-8ABB-3FAB06132297

Q35143874-288FA737-38E3-4A3B-A9FA-37464AF7DA88

Q35143874-3125A7C3-17DD-4FDC-B5AE-A045D29BF523

Q35143874-343C0BAC-622E-44E0-84A0-DB5B26D6C22C

Q35143874-35B4B4EE-C05C-4721-AFE1-DBFAD3F7F76E

Q35143874-3EB57717-382E-4B5C-9D19-AFFBBCFF5D4F

Q35143874-44022701-EBD1-4E00-B9BA-CA5813903EFA

P304

Q35143874-0DCB2D65-8E59-4ADD-B724-CE8232DAD748

P31

Q35143874-E9DF8FAA-C4A0-41EF-8460-C1A2014BBD60

P356

Q35143874-7B5C2719-5095-404D-B50D-71BE5B54930B

P407

Q35143874-FA93CD75-8174-4FCF-8FCF-41DAEEC6D9E4

P433

Q35143874-D5F9A2F2-417F-457F-8741-1D3D86B88549

P478

Q35143874-2BDBED29-377C-4C1E-824A-85CB3F0BA683

P50

Q35143874-0D97FAC5-4E4F-4558-B775-2137AB8ADF1F

Q35143874-223E8184-8850-4D5D-8132-CF41F32CC8D3

Q35143874-64A3B541-7F87-4A0B-B262-C77EDCD26C69

Q35143874-917B59E6-DB81-44DA-9FBC-5FB45B1BDFAA

P577

Q35143874-3EFD7C10-6380-4325-9333-8BC3F221E2CF

P5875

Q35143874-A0D31A41-6150-466C-8199-94E51E5AAD08

P698

Q35143874-54A2A7D3-4DB7-456A-ACD2-DD3595A0FCB7

P921

Q35143874-1A214D54-9830-492F-B2E7-3541EF0E5033

Q35143874-739E5D2C-6787-43B0-91BF-988C42FD4681

P932

Q35143874-93575812-3D61-4BB5-BD54-C9C3A10F8908

P356

PNAS.1135726100

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions

@en

P2093

Alessandra Ciervo

http://www.w3.org/2001/XMLSchema#string

Amedeo Amedei

http://www.w3.org/2001/XMLSchema#string

Annalisa Azzurri

http://www.w3.org/2001/XMLSchema#string

Antonio Cassone

http://www.w3.org/2001/XMLSchema#string

Carlo Tamburini

http://www.w3.org/2001/XMLSchema#string

Cosima T Baldari

http://www.w3.org/2001/XMLSchema#string

Gianfranco Del Prete

http://www.w3.org/2001/XMLSchema#string

Marisa Benagiano

http://www.w3.org/2001/XMLSchema#string

Sergio Romagnani

http://www.w3.org/2001/XMLSchema#string

P2860

Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells

Atherosclerosis — An Inflammatory Disease

Infection and atherosclerosis: emerging mechanistic paradigms.

The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae.

Antibodies to 60-kilodalton heat shock protein and outer membrane protein 2 of Chlamydia pneumoniae in patients with coronary heart disease.

Atherosclerosis as an autoimmune disease: an update.

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.

Current perspective on the role of apoptosis in atherothrombotic disease.

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.

Immune mechanisms in atherosclerosis.

P304

6658-6663

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1135726100

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Mario Milco D'Elios

P577

2003-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7313934

http://www.w3.org/2001/XMLSchema#string

P698

12740434

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

164503

http://www.w3.org/2001/XMLSchema#string